Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the inherent actions of GLP-1, a hormone released by the https://bookmarklogin.com/story20919147/reta-glucagon-like-peptide-1-receptor-agonists